Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: A study of 44 patients from Argentina

Annals of Diagnostic Pathology

Volumn 17, Issue 3, 2013, Pages 250-255

  Bürgesser, María Virginia ^a   Gualco, Gabriela ^b   Diller, Ana ^a   Natkunam, Yasodha ^c   Bacchi, Carlos E ^b  

^a HOSPITAL PRIVADO   (Argentina)

^b Consultoria em Patologia ^*  (Brazil)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggressive B cell lymphoma; Burkitt lymphoma; Diffuse large B cell lymphoma; Grey zone lymphoma; Immunohistochemistry; Malignant lymphoma; Unclassifiable

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MYC PROTEIN; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; TRANSCRIPTION FACTOR SOX11; VINCRISTINE;

ADULT; AGED; ARGENTINA; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNATIONAL PROGNOSTIC INDEX; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; ARGENTINA; BURKITT LYMPHOMA; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; SOXC TRANSCRIPTION FACTORS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84877705670     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2012.11.001     Document Type: Article

References (34)

1. S.C.E. Swerdlow, N.L. Harris, E.S. Jaffe, S. Pileri, H. Stein, and J. Thiele World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues 4th ed 2008 IARC Press Lyon, France 233 265
2. E.S. Jaffe, and S. Pittaluga Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification Hematology Am Soc Hematol Educ Program 2011 2011 506 514 [Epub 2011/12/14]
3. S.M. Aukema, R. Siebert, and E. Schuuring Double-hit B-cell lymphomas Blood 117 8 2011 2319 2331 [Epub 2010/12/02]
4. M. Snuderl, O.K. Kolman, and Y.B. Chen B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma Am J Surg Pathol 34 3 2010 327 340 [Epub 2010/02/02]
5. S. Li, P. Lin, and L.E. Fayad B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome Mod Pathol 25 1 2012 145 156 [Epub 2011/10/18]
6. S.F. Paternoster, S.R. Brockman, R.F. McClure, E.D. Remstein, P.J. Kurtin, and G.W. Dewald A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization Am J Pathol 160 6 2002 1967 1972 [Epub 2002/06/12] (Pubitemid 34663389)
7. B.L. Petersen, M.C. Sorensen, S. Pedersen, and M. Rasmussen Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method Appl Immunohistochem Mol Morphol 12 3 2004 259 265 [Epub 2004/11/24]
8. L. de Leval, and R.P. Hasserjian Diffuse large B-cell lymphomas and burkitt lymphoma Hematol Oncol Clin North Am 23 4 2009 791 827 [Epub 2009/07/07]
9. N. Nakamura, H. Nakamine, and J. Tamaru The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement Mod Pathol 15 7 2002 771 776 [Epub 2002/07/16] (Pubitemid 34787314)
10. A. Kanungo, L.J. Medeiros, L.V. Abruzzo, and P. Lin Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis Mod Pathol 19 1 2006 25 33 [Epub 2005/11/01] (Pubitemid 43250976)
11. S.S. Chuang, H. Ye, and M.Q. Du Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH Am J Clin Pathol 128 4 2007 558 564 [Epub 2007/09/19] (Pubitemid 47584432)
12. N. Niitsu, M. Okamoto, I. Miura, and M. Hirano Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations Leukemia 23 4 2009 777 783 [Epub 2009/01/20]
13. W.W. Choi, D.D. Weisenburger, and T.C. Greiner A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy Clin Cancer Res 15 17 2009 5494 5502 [Epub 2009/08/27]
14. K.J. Savage, N.A. Johnson, and S. Ben-Neriah MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy Blood 114 17 2009 3533 3537 [Epub 2009/08/26]
15. A. Rosenwald, and G. Ott Ann Oncol 19 Suppl. 4 2008 iv67 iv69 [Epub 2008/06/27]
16. D.W. Sevilla, J.Z. Gong, and B.K. Goodman Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation Am J Clin Pathol 128 6 2007 981 991 [Epub 2007/11/21]
17. E. Haralambieva, E.J. Boerma, and G.W. van Imhoff Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma Am J Surg Pathol 29 8 2005 1086 1094 [Epub 2005/07/12] (Pubitemid 41045555)
18. A. Carbone, A. Gloghini, A. Aiello, A. Testi, and A. Cabras B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol 41 5 2010 621 631 [Epub 2010/04/20]
19. N. Kurita, H. Nishikii, and R. Nakamoto A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma J Clin Exp Hematop 51 1 2011 37 42 [Epub 2011/06/02]
20. R.F. McClure, E.D. Remstein, and W.R. Macon Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior Am J Surg Pathol 29 12 2005 1652 1660 [Epub 2005/12/06]
21. S. Le Gouill, P. Talmant, and C. Touzeau The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement Haematologica 92 10 2007 1335 1342 [Epub 2007/11/21] (Pubitemid 350144150)
22. I. Salaverria, and R. Siebert The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective J Clin Oncol 29 14 2011 1835 1843 [Epub 2011/04/13]
23. N. Tomita, M. Tokunaka, and N. Nakamura Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations Haematologica 94 7 2009 935 943 [Epub 2009/06/19]
24. N. Tomita BCL2 and MYC dual-hit lymphoma/leukemia J Clin Exp Hematop 51 1 2011 7 12 [Epub 2011/06/02]
25. N.A. Johnson, K.J. Savage, and O. Ludkovski Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival Blood 114 11 2009 2273 2279 [Epub 2009/07/15]
26. C. Bellan, L. Stefano, F. Giulia de, E.A. Rogena, and L. Lorenzo Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach Hematol Oncol 28 2 2010 53 56 [Epub 2009/10/22]
27. P. Lin, T.J. Dickason, and L.E. Fayad Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma Cancer 118 6 2012 1566 1573 [Epub 2011/09/02]
28. J.Y. Ahn, Y.H. Seo, and P.W. Park A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child Ann Lab Med 32 2 2012 162 166 [Epub 2012/03/06]
29. S. Hoeller, and C. Copie-Bergman Grey zone lymphomas: lymphomas with intermediate features Adv Hematol 2012 2012 460801 [Epub 2012/05/02]
30. M. Frick, B. Dorken, and G. Lenz New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma Best Pract Res Clin Haematol 25 1 2012 3 12 [Epub 2012/03/14]
31. Y.H. Chen, J. Gao, G. Fan, and L.C. Peterson Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms Mod Pathol 23 1 2010 105 112 [Epub 2009/10/06]
32. M. Dictor, S. Ek, and M. Sundberg Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma Haematologica 94 11 2009 1563 1568 [Epub 2009/11/03]
33. M.C. Vegliante, C. Royo, and J. Palomero Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications PLoS One 6 6 2011 e21382 [Epub 2011/07/09]
34. N. Macpherson, D. Lesack, and R. Klasa Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation J Clin Oncol 17 5 1999 1558 1567 [Epub 1999/05/20]